Status:
COMPLETED
Retrospective Analysis of Colorectal Cancer Screening Results
Lead Sponsor:
Creative Biosciences (Guangzhou) Co., Ltd.
Collaborating Sponsors:
Dongguan Shipai Hospital
Conditions:
Colorectal Cancer
Advanced Adenocarcinoma
Eligibility:
All Genders
40-74 years
Brief Summary
The purpose of this study is to retrospectively analyze colorectal cancer screening data of 40-74 year old population in Shipai Town, Dongguan City. In this study, the data of SDC2 Gene Methylation T...
Detailed Description
This study is a retrospective and observational study. Subjects were not be given or offered any treatment during the study. The investigator reviewed the patient's medical history and examination rep...
Eligibility Criteria
Inclusion
- Subjects must meet both of the following criteria to be eligible for the study:
- Subjects with positive SDC2 Gene Methylation Test and/or Q-FIT;
- Subjects with colonoscopy and/or pathological results.
Exclusion
- Subject with any of the following conditions shall be excluded:
- Data Missing or damaged;
- Unqualified colonoscopy or unqualified stool test.
Key Trial Info
Start Date :
March 29 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 28 2022
Estimated Enrollment :
822 Patients enrolled
Trial Details
Trial ID
NCT05374369
Start Date
March 29 2022
End Date
April 28 2022
Last Update
July 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dongguan Shipai Hospital
Dongguan, Guangdong, China